Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-guided Therapy vs Beta Blockers for Gastric Varices
NCT05859009Withdrawn
- Sponsor
- Unity Health Toronto
- Start
- Jul 2023
- Primary completion
- Jul 2025
01
Overview
Randomised, open-label trial (3 arms), sponsored by Unity Health Toronto. Primary endpoint: Assessment of NSBB (Propanolol), EUS-guided combined therapy (coils + glue) of GOV-2 and IGV-1 at 9 months. Planned start Jul 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT05859009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05859009.